Demoxytocin
From Wikipedia, the free encyclopedia
Demoxytocin | |
---|---|
![]() |
|
2-[(1-{[13-(butan-2-yl)-10-(2-carbamoylethyl)-7-(carbamoylmethyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}pyrrolidin-2-yl)formamido]-N-(carbamoylmethyl)-4-methylpentanamide |
|
Identifiers | |
CAS number | 113-78-0 |
PubChem | 8229 |
KEGG | D07228 ![]() |
MeSH | deaminooxytocin |
ATC code | H01 |
Jmol-3D images | Image 1 |
|
|
Properties | |
Molecular formula | C43H65N11O12S2 |
Molar mass | 992.17 g mol−1 |
![]() ![]() ![]() Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) |
|
Infobox references |
Demoxytocin (INN, trade name Sandopart) or deaminooxytocin, is an obstetric drug often[citation needed] used in the prevention of puerperal mastitis.[1] It is an analogue of oxytocin.
[edit] References
|
|
|
![]() |
This hormonal preparation article is a stub. You can help Wikipedia by expanding it. |
![]() |
This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |
![]() |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |